Perspective Therapeutics, Inc. (CATX)
AMEX·Healthcare·Medical - Devices
$4.00
-6.32%
Mkt Cap $332.24M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | $232.48K | $43.00K | -81.50% | -$0.37 | -$0.51 | -37.84% | — | — |
| Q4 2025 Nov 10, 2025 | $232.48K | $209.00K | -10.10% | -$0.33 | -$0.35 | -6.06% | — | — |
| Q3 2025 Aug 13, 2025 | $174.60K | $234.00K | +34.02% | -$0.30 | -$0.30 | +0.00% | — | — |
| Q2 2025 May 12, 2025 | $185.86K | $342.00K | +84.01% | -$0.28 | -$0.25 | +10.71% | — | — |
| Q1 2025 Mar 26, 2025 | $277.30K | $234.00K | -15.61% | -$0.26 | -$0.25 | +3.85% | — | — |
| Q4 2024 Nov 12, 2024 | $292.76K | $369.00K | +26.04% | -$0.21 | -$0.21 | +0.00% | — | — |
| Q3 2024 Aug 12, 2024 | $183.48K | $526.00K | +186.68% | -$0.21 | -$0.17 | +19.05% | — | — |
| Q2 2024 May 15, 2024 | $368.80K | $325.00K | -11.88% | -$0.30 | -$0.20 | +33.33% | — | — |
| Q1 2024 Feb 15, 2024 | $1.80M | $337.00K | -81.28% | -$0.04 | -$0.02 | +50.00% | — | — |
| Q4 2023 Nov 14, 2023 | $1.85M | $1.91M | +3.19% | -$0.40 | -$0.40 | +0.00% | — | — |
| Q3 2023 Aug 11, 2023 | $2.60M | $1.50M | -42.31% | -$0.30 | -$0.40 | -33.33% | — | — |
| Q2 2023 May 15, 2023 | $2.06M | $1.83M | -11.17% | -$0.01 | -$0.01 | +0.00% | — | — |
| Q1 2023 Feb 16, 2023 | $2.95M | $1.83M | -37.78% | -$0.01 | -$0.02 | -100.00% | — | — |
| Q4 2022 Nov 14, 2022 | $2.49M | $1.72M | -30.92% | -$0.01 | -$0.03 | -200.00% | — | — |
| Q3 2022 Sep 28, 2022 | $2.84M | $2.50M | -11.92% | -$0.01 | -$0.01 | +0.00% | — | — |
| Q2 2022 May 10, 2022 | $2.91M | $2.91M | +0.00% | -$0.01 | -$0.01 | -33.33% | — | — |
| Q1 2022 Feb 8, 2022 | $2.95M | $2.82M | -4.54% | -$0.01 | -$0.01 | -33.33% | — | — |
| Q4 2021 Nov 10, 2021 | $2.82M | $2.56M | -9.09% | -$0.01 | -$0.02 | -100.00% | — | — |
| Q3 2021 Sep 21, 2021 | $2.70M | $2.71M | +0.37% | -$0.01 | -$0.01 | +0.00% | — | — |
| Q2 2021 May 13, 2021 | $2.60M | $2.60M | +0.00% | -$0.01 | -$0.01 | +0.00% | — | — |